Literature DB >> 1672434

Treatment of HBV reactivation after withdrawal of immunosuppression.

J Y Lau, G L Bird, A E Gimson, G J Alexander, R Williams.   

Abstract

Mesh:

Substances:

Year:  1991        PMID: 1672434     DOI: 10.1016/0140-6736(91)91433-u

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Reactivation of precore mutant hepatitis B virus leading to fulminant hepatic failure following cytotoxic treatment.

Authors:  M Yoshiba; K Sekiyama; F Sugata; H Okamoto; K Yamamoto; S Yotsumoto
Journal:  Dig Dis Sci       Date:  1992-08       Impact factor: 3.199

2.  Corticosteroid and nucleoside analogue for hepatitis B virus-related acute liver failure.

Authors:  Keiichi Fujiwara; Shin Yasui; Osamu Yokosuka
Journal:  World J Gastroenterol       Date:  2015-09-28       Impact factor: 5.742

Review 3.  Viral hepatitis.

Authors:  J Y Lau; G J Alexander; A Alberti
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

4.  Efficacy of combination therapy of antiviral and immunosuppressive drugs for the treatment of severe acute exacerbation of chronic hepatitis B.

Authors:  Keiichi Fujiwara; Shin Yasui; Yutaka Yonemitsu; Kenichi Fukai; Makoto Arai; Fumio Imazeki; Akihiro Suzuki; Hiroshi Suzuki; Tomohito Sadahiro; Shigeto Oda; Osamu Yokosuka
Journal:  J Gastroenterol       Date:  2008-09-20       Impact factor: 7.527

5.  The requirement for a sufficient period of corticosteroid treatment in combination with nucleoside analogue for severe acute exacerbation of chronic hepatitis B.

Authors:  Keiichi Fujiwara; Shin Yasui; Koichiro Okitsu; Yutaka Yonemitsu; Shigeto Oda; Osamu Yokosuka
Journal:  J Gastroenterol       Date:  2010-07-09       Impact factor: 7.527

6.  Hepatitis B reactivation after chemotherapy: two decades of clinical research.

Authors:  George K K Lau
Journal:  Hepatol Int       Date:  2008-03-05       Impact factor: 6.047

7.  Importance of adequate immunosuppressive therapy for the recovery of patients with "life-threatening" severe exacerbation of chronic hepatitis B.

Authors:  Keiichi Fujiwara; Osamu Yokosuka; Hiroshige Kojima; Tatsuo Kanda; Hiromitsu Saisho; Hiroyuki Hirasawa; Hiroshi Suzuki
Journal:  World J Gastroenterol       Date:  2005-02-28       Impact factor: 5.742

8.  Recovery from life-threatening, corticosteroid-unresponsive, chemotherapy-related reactivation of hepatitis B associated with lamivudine therapy.

Authors:  F ter Borg; S Smorenburg; R A de Man; R C Rietbroek; R A Chamuleau; E A Jones
Journal:  Dig Dis Sci       Date:  1998-10       Impact factor: 3.199

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.